Literature DB >> 10830566

Prognostic significance of antisocial personality disorder in cocaine-dependent patients entering continuing care.

J R McKay1, A I Alterman, J S Cacciola, F D Mulvaney, C P O'Brien.   

Abstract

This study examined the relationship of antisocial personality disorder (APD) to response to continuing care treatments in a sample of cocaine-dependent patients. Patients (N = 127) were randomly assigned to 20-week standard group or individualized relapse prevention continuing care interventions after the completion of an initial treatment episode and followed up at 3, 6, and 12 months. APD and non-APD patients did not differ on retention in continuing care, substance use outcomes, social function outcomes, or experiences before or during cocaine relapse episodes. A diagnosis of APD was also not a predictor of differential response to the two continuing care interventions in the study. However, APD patients had worse medical and psychiatric problem severity than non-APD patients at entrance to continuing care and during follow-up. These results suggest that cocaine patients with APD who are in the continuing care phase of outpatient rehabilitation might benefit from additional medical and psychiatric treatment services.

Entities:  

Mesh:

Year:  2000        PMID: 10830566     DOI: 10.1097/00005053-200005000-00006

Source DB:  PubMed          Journal:  J Nerv Ment Dis        ISSN: 0022-3018            Impact factor:   2.254


  11 in total

1.  Relationship between cocaine use and mental health problems in a sample of European cocaine powder or crack users.

Authors:  Christian Haasen; Michael Prinzleve; Michael Gossop; Gabriele Fischer; Miguel Casas
Journal:  World Psychiatry       Date:  2005-10       Impact factor: 49.548

Review 2.  Illusory predictors: Generalizability of findings in cocaine treatment retention research.

Authors:  Angela L Stotts; Marc E Mooney; Shelly L Sayre; Meredith Novy; Joy M Schmitz; John Grabowski
Journal:  Addict Behav       Date:  2007-05-03       Impact factor: 3.913

3.  Antisocial behavioral syndromes and DSM-IV drug use disorders in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions.

Authors:  Risë B Goldstein; Wilson M Compton; Attila J Pulay; W June Ruan; Roger P Pickering; Frederick S Stinson; Bridget F Grant
Journal:  Drug Alcohol Depend       Date:  2007-04-12       Impact factor: 4.492

Review 4.  Psychological interventions for antisocial personality disorder.

Authors:  Simon Gibbon; Conor Duggan; Jutta Stoffers; Nick Huband; Birgit A Völlm; Michael Ferriter; Klaus Lieb
Journal:  Cochrane Database Syst Rev       Date:  2010-06-16

5.  Antisocial behavioral syndromes and additional psychiatric comorbidity in posttraumatic stress disorder among u.s. Adults: results from wave 2 of the national epidemiologic survey on alcohol and related conditions.

Authors:  Risë B Goldstein; Wilson M Compton; Bridget F Grant
Journal:  J Am Psychiatr Nurses Assoc       Date:  2010-05       Impact factor: 2.385

6.  Antisocial personality disorder is associated with receipt of physical disability benefits in substance abuse treatment patients.

Authors:  Shannon A Byrne; Martin G Cherniack; Nancy M Petry
Journal:  Drug Alcohol Depend       Date:  2013-02-06       Impact factor: 4.492

7.  Psychopathology in methamphetamine-dependent adults 3 years after treatment.

Authors:  Suzette Glasner-Edwards; Larissa J Mooney; Patricia Marinelli-Casey; Maureen Hillhouse; Alfonso Ang; Richard A Rawson
Journal:  Drug Alcohol Rev       Date:  2010-01

8.  Psychological interventions for antisocial personality disorder.

Authors:  Simon Gibbon; Najat R Khalifa; Natalie H-Y Cheung; Birgit A Völlm; Lucy McCarthy
Journal:  Cochrane Database Syst Rev       Date:  2020-09-03

9.  Dialectical behavior therapy for substance abusers.

Authors:  Linda A Dimeff; Marsha M Linehan
Journal:  Addict Sci Clin Pract       Date:  2008-06

10.  Protocol: Personality assessment as a support for referral and case-work in treatment for substance use disorders (PASRC-study).

Authors:  Morten Hesse; Mads K Pedersen
Journal:  BMC Psychiatry       Date:  2008-04-25       Impact factor: 3.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.